Current Opinion in Lipidology volume 27, issue 3, P216-224 2016 DOI: 10.1097/mol.0000000000000308 View full text
|
|
Share
Zheng Wang, Debby Koonen, Marten Hofker, Jingyuan Fu

Abstract: The gut microbiome is transitioning from being a 'missing' organ to a potential target for therapeutic applications. Due to the complex interplay between the gut microbiome, the host genome, and diet, a systematic approach is required to pave the way for therapeutic development.